Prostate News Archive
29-Jan-2007
Annual study finds top hospitals have 28 percent lower mortality rate (EurekAlert!)
On average, a 28 percent lower risk of mortality was experienced by Medicare patients at Distinguished Hospitals for Clinical Excellence in the following procedures and diagnoses: cardiac surgery, angioplasty and stent, heart attack, heart failure, atrial fibrillation, chronic obstructive pulmonary disease, community-acquired pneumonia, stroke, abdominal aortic aneurysm repair, bowel obstruction, ... PROSTATE TREATMENT WARNING (Daily Record)
prostate cancer treatment can significantly reduce penis length, a new study suggests. Turkish researchers studied 47 men with advanced prostate cancer who received hormone therapy followed by radiation treatment. Ciphergen Announces Issuance Of European Patent Covering A Method For Aiding Prostate Cancer Diagnosis (Medical News Today)
Ciphergen Biosystems, Inc. (Nasdaq: CIPH) today announced that the European Patient Office (EPO) has issued EU Patent No. 1 224 466, entitled "Prostate Cancer Marker Proteins," for aiding in prostate cancer diagnosis. [click link for full article] CEO to donate $1M to prostate cancer research (bizjournals.com via Yahoo! Finance)
A Dayton area executive will give one million dollars to prostate cancer research if the same amount is donated by by the end of the year to the National prostate Cancer Coaltion.
Back to Prostate News Archive
